Microbiome Track

Saturday, 5 December 2015

10:30 - 12:00

Microbiome Track 1: Technology of the Microbiome
Majestic Ballroom (Trump National Doral)
Chairpersons: Augusto Litonjua (US)
10:30 - 10:35
Welcoming Remarks
10:35 - 11:00
MB 1-1: Next Steps of Microbiome Analysis | Yvonne Huang (United States)
11:00 - 11:25
MB 1-2: Overview of Technology of the Microbiome | Cathryn Nagler (United States)
11:25 - 11:50
MB 1-3: Informatics: Analysis of Big Data | John Tsang (United States)
11:50 - 12:00
Discussion

13:30 - 15:00

Microbiome Track 2: Description of the Microbiome: Evolution and Life Course
Majestic Ballroom (Trump National Doral)
Chairpersons: Luis Caraballo (Colombia) , Roy Gerth Van Wijk (Netherlands)
13:30 - 13:35
Welcoming Remarks
13:35 - 14:00
MB 2-1: The Microbiome and Early Life Immunity | Harald Renz (Germany)
14:00 - 14:25
MB 2-2: Establishment of the Infant Gut-Microbiome | Christina West (Sweden)
14:25 - 14:50
14:50 - 15:00
Discussion

15:30 - 17:00

Microbiome Track 3: Mechanisms of Host and Microbiome Interaction: Implications in Health and Disease
Majestic Ballroom (Trump National Doral)
Chairpersons: Ignacio J. Ansotegui (Spain)
15:30 - 15:35
Welcoming Remarks
15:35 - 16:00
16:00 - 16:25
16:25 - 16:50
16:50 - 17:00
Discussion

Sunday, 6 December 2015

08:00 - 09:30

Microbiome Track 4: Role of the Microbiome in the Development and Modulation of ‘Barrier Diseases’
Majestic Ballroom (Trump National Doral)
Chairpersons: Sergio Bonini (Italy) , Mario Zernotti (Argentina)
08:00 - 08:05
Welcoming Remarks
08:05 - 08:30
08:30 - 08:55
08:55 - 09:20
MB 4-3: Late Onset Respiratory Allergy: The Role of the Local | Claus Bachert (Belgium)
09:20 - 09:30
Discussion

10:00 - 11:30

Microbiome Track 5 : Interventions to Modulate the Microbiome in the Treatment and Prevention of Inflammatory Disease
Majestic Ballroom (Trump National Doral)
Chairpersons: Zeinab A El-Sayed (Egypt) , Jose Ortega Martell (Mexico)
10:00 - 10:05
Welcoming Remarks
10:05 - 10:30
MB 5 -1: Prebiotics | Susan Prescott (Australia)
10:30 - 10:55
MB 5 -2: Probiotics | Alessandro Fiocchi (Vatican City)
10:55 - 11:20
MB 5 -3: Development of Novel Live Biotherapeutics | Cathryn Nagler (United States)
11:20 - 11:30
Discussion